Ocular Therapeutix Undertakes $475 Million Stock Offering

WilmerHale has advised Ocular Therapeutix and Cooley has advised the underwriters.Ocular Therapeutix, Inc., an integrated biopharmaceutical company, conducted an underwritten offering of 37,909,018 shares of its…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here
  Share:

Author: Leila Ahmed

…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here